Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurobiology of Disease

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2013.10.007PMID 24141019PMCID PMC3877710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013cited by this paper
• Clinical targeting of the TNF and TNFR superfamilies

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism.

  2012cited by this paper
• Neuronal Cell Cycle Re-Entry Markers are Altered in the Senescence Accelerated Mouse P8 (SAMP8)

  2012cited by this paper
• Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response.

  2012cited by this paper
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

  2011cited by this paper
• Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease

  2011cited by this paper
• T Cells Specifically Targeted to Amyloid Plaques Enhance Plaque Clearance in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• DNA damage and cell cycle events implicate cerebellar dentate nucleus neurons as targets of Alzheimer's disease

  2010cited by this paper
• Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity*

  2010cited by this paper
• The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

  2009cited by this paper
• Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

  2008cited by this paper
• Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.

  2008cited by this paper
• Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

  2008cited by this paper
• Aβ Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease

  2008cited by this paper
• NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies.

  2007cited by this paper
• Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?

  2007cited by this paper
• Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease

  2007cited by this paper
• Cell division in the CNS: protective response or lethal event in post-mitotic neurons?

  2007cited by this paper
• Rewired ERK-JNK signaling pathways in melanoma.

  2007cited by this paper
• Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons through TNF‐α‐mediated induction of Bax and phosphorylated c‐Jun NH2‐terminal kinase

  2007cited by this paper
• Role of Cell Cycle Proteins in CNS Injury

  2007cited by this paper
• Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.

  2007cited by this paper
• Monoclonal antibodies that target pathological assemblies of Aβ

  2007cited by this paper
• Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

  2007cited by this paper
• Tumor necrosis factor α triggers proliferation of adult neural stem cells via IKK/NF-κB signaling

  2006cited by this paper
• Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models

  2006cited by this paper
• Chemical genetic analysis of the time course of signal transduction by JNK.

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Control of microglial neurotoxicity by the fractalkine receptor

  2006cited by this paper
• Induction of apoptosis and cell cycle arrest by a specific c-Jun NH2-terminal kinase (JNK) inhibitor, SP-600125, in gastrointestinal cancers.

  2006cited by this paper
• Role of the Cell Cycle in the Pathobiology of Central Nervous System Trauma

  2005cited by this paper
• Network communications: lymphotoxins, LIGHT, and TNF.

  2005cited by this paper
• β‐amyloid inhibition of long‐term potentiation is mediated via tumor necrosis factor

  2005cited by this paper
• Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3‐kinase‐mediated intracellular signaling

  2005cited by this paper
• Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor.

  2005cited by this paper
• Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

  2005cited by this paper
• Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.

  2005cited by this paper
• Hypoxia-Ischemia Induces DNA Synthesis without Cell Proliferation in Dying Neurons in Adult Rodent Brain

  2004cited by this paper
• Inflammation occurs early during the Aβ deposition process in TgCRND8 mice

  2004cited by this paper
• In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis*

  2003cited by this paper
• Expression Patterns of Retinoblastoma Protein in Parkinson Disease

  2003cited by this paper
• Gene profiling in spinal cord injury shows role of cell cycle in neuronal death

  2003cited by this paper
• High‐yield isolation of murine microglia by mild trypsinization

  2003cited by this paper
• Altered Distribution of Cell Cycle Transcriptional Regulators during Alzheimer Disease

  2002cited by this paper
• Human Brain Parenchymal Microglia Express CD14 and CD45 and are Productively Infected by HIV‐1 in HIV‐1 Encephalitis

  2002cited by this paper
• Cell Cycle Proteins Exhibit Altered Expression Patterns in Lentiviral-Associated Encephalitis

  2002cited by this paper
• beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

  2001cited by this paper
• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

  2001cited by this paper
• c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

  2001cited by this paper
• Immune function of microglia

  2001cited by this paper
• CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosis

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.

  2001cited by this paper
• β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis

  2001cited by this paper
• Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia

  2000cited by this paper
• Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons.

  2000cited by this paper
• Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative.

  2000cited by this paper
• Cell mediators of inflammation in the Alzheimer disease brain.

  2000cited by this paper
• Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

  2000cited by this paper
• Cyclin-dependent kinases as a therapeutic target for stroke.

  2000cited by this paper
• Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma.

  1999cited by this paper
• Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation.

  1999cited by this paper
• A high plasma concentration of TNF-alpha is associated with dementia in centenarians.

  1999cited by this paper
• Tumor Necrosis Factor Induces DNA Replication in Hepatic Cells through Nuclear Factor {{kappa}}B Activation

  1999cited by this paper
• α-MSH Peptides Inhibit Production of Nitric Oxide and Tumor Necrosis Factor-α by Microglial Cells Activated with β-Amyloid and Interferon γ

  1999cited by this paper
• Microglia exhibit clonal variability in eliciting cytotoxic T lymphocyte responses independent of class I expression.

  1999cited by this paper
• Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide

  1998cited by this paper
• Tau interacts with src-family non-receptor tyrosine kinases.

  1998cited by this paper
• Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain

  1998cited by this paper
• Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide.

  1998cited by this paper
• TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin.

  1997cited by this paper
• Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control.

  1997cited by this paper
• Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice.

  1997cited by this paper
• Cell cycle markers in the hippocampus in Alzheimer’s disease

  1997cited by this paper
• Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response

  1996cited by this paper
• Mitotic mechanisms in Alzheimer's disease?

  1996cited by this paper
• The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.

  1996influential reference
• Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease

  1996cited by this paper
• The induction of multiple cell cycle events precedes target-related neuronal death.

  1995cited by this paper
• Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

  1993cited by this paper
• Requirement for a functional Rb-1 gene in murine development

  1992cited by this paper
• Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice.

  1992cited by this paper
• Effects of an Rb mutation in the mouse

  1992cited by this paper
• Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

  1992cited by this paper
• Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice.

  1992cited by this paper
• Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

  1991cited by this paper
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage

  1981cited by this paper

• Intranasal Human NSC‐Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS‐STING Signalling, in Aged Hippocampus

  2026influential citation
• Demyelinated lesion associated compartmental inflammation in progressive multiple sclerosis brains

  2025cites this paper
• Unraveling the genetic underpinnings of mitochondrial traits and associated circulating inflammatory proteins in Alzheimer's disease: Mitochondrial HtrA2-T cell CD5 negative axis

  2025cites this paper
• Cooperative multi-view integration with Scalable and Interpretable Model Explainer

  2025cites this paper
• Involvement of inflammasomes in the pathogenesis of Alzheimer's disease

  2024cites this paper
• Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma

  2024cites this paper
• Olanzapine attenuates amyloid-β-induced microglia-mediated progressive neurite lesions.

  2024cites this paper
• The Mechanistic Link Between Tau-Driven Proteotoxic Stress and Cellular Senescence in Alzheimer’s Disease

  2024cites this paper
• Ellagic acid(EA) ameliorates Alzheimer's disease by reducing Aβ levels, oxidative stress and attenuating inflammation.

  2024cites this paper
• From defense to disease: IFITM3 in immunity and Alzheimer's disease

  2024cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Multidirectional associations between the gut microbiota and Parkinson’s disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway

  2023cites this paper
• Immunity impacts cognitive deficits across neurological disorders

  2023cites this paper
• Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury.

  2023cites this paper
• Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease‐related amyloidosis

  2023cites this paper
• TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease.

  2023cites this paper
• Alzheimer’s Disease and Its Possible Evolutionary Origin: Hypothesis

  2023cites this paper
• Microglia-derived TNF-α contributes to RVLM neuronal mitochondrial dysfunction via blocking the AMPK–Sirt3 pathway in stress-induced hypertension

  2023cites this paper
• The Immunopathy of Alzheimer's Disease: Innate or Adaptive?

  2023cites this paper
• Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer’s Disease

  2023cites this paper
• Research Progress on the Etiology and Pathogenesis of Alzheimer's Disease from the Perspective of Chronic Stress

  2022cites this paper
• The role of transforming growth factor β1 /Smad pathway in Alzheimer’s disease inflammation pathology

  2022cites this paper
• Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons

  2022cites this paper
• Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications

  2022cites this paper
• The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease.

  2022cites this paper
• Seizures in PPT1 Knock-In Mice Are Associated with Inflammatory Activation of Microglia

  2022cites this paper
• Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases

  2022cites this paper
• Regulation of neuroinflammation with GLP-1 receptor targeting nanostructures to alleviate Alzheimer’s symptoms in the disease models

  2022cites this paper
• Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer’s disease

  2022cites this paper
• Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer’s Disease

  2021cites this paper
• Identifying a Population of Glial Progenitors That Have Been Mistaken for Neurons in Embryonic Mouse Cortical Culture

  2021influential citation
• A Pilot randomized clinical trial of adapted tango to improve cognition and psychosocial function in African American women with family history of Alzheimer's disease (ACT trial)

  2021cites this paper
• Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury.

  2021cites this paper
• Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling.

  2021cites this paper
• Pharmacological relevance of CDK inhibitors in Alzheimer's disease.

  2021cites this paper
• Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease

  2021cites this paper
• Beneficial effects of angiotensin converting enzyme inhibition on scopolamine-induced learning and memory impairment in rats, the roles of brain-derived neurotrophic factor, nitric oxide and neuroinflammation

  2021cites this paper
• Stress and Alzheimer's Disease: A Senescence Link?

  2020cites this paper
• Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease.

  2020cites this paper
• Context dependent cytokine secretion by stem cell derived microglia in vitro

  2020cites this paper
• Recent updates in the Alzheimer's disease etiopathology and possible treatment approaches: a narrative review of current clinical trials.

  2020cites this paper
• Atorvastatin has therapeutic potential for the fatty liver-induced memory dysfunction in rats, likely via its antioxidant and anti-inflammatory properties

  2020cites this paper
• A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

  2020influential citation
• “Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease

  2020cites this paper
• Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer’s disease mouse model

  2020cites this paper
• Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets

  2020cites this paper
• GSK3‐ARC/Arg3.1 and GSK3‐Wnt signaling axes trigger amyloid‐β accumulation and neuroinflammation in middle‐aged Shugoshin 1 mice

  2020cites this paper
• CISD2 Attenuates Inflammation and Regulates Microglia Polarization in EOC Microglial Cells—As a Potential Therapeutic Target for Neurodegenerative Dementia

  2020cites this paper
• Long-term effects of experimental carotid stenosis on hippocampal infarct pathology, neurons and glia and amelioration by environmental enrichment.

  2020cites this paper
• The role of innate immunity in Alzheimer's disease

  2020cites this paper
• Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.

  2020cites this paper
• Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.

  2020cites this paper
• Inflammasome-Mediated Inflammation in Neurodegenerative Diseases

  2019cites this paper
• Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.

  2019cites this paper
• Stepwise targeted matching strategy from in vitro to in vivo based on ultra-high performance liquid chromatography tandem mass spectrometry technology to quickly identify and screen pharmacodynamic constituents.

  2019cites this paper
• Testing the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay

  2019cites this paper
• Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.

  2019cites this paper
• Tackling Alzheimer's disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents.

  2019cites this paper
• Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway

  2019cites this paper
• Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy

  2019cites this paper
• p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model

  2019cites this paper
• The Links between Brain Insulin Resistance and Alzheimer’s Disease

  2019cites this paper
• Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer’s molecular signatures

  2019cites this paper
• Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges?

  2019cites this paper
• Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

  2019cites this paper
• The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.

  2019cites this paper
• TAUOPATHIES, NOVEL OPTOGENETIC TOOLS, AND THE FUTURE OF ARTIFICIAL INTELLIENCE IN MEDICINE.

  2019cites this paper
• The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis

  2019cites this paper
• Targeting Neuroin fl ammation as a Therapeutic Strategy for Alzheimer ’ s Disease : Mechanisms , Drug Candidates , and New Opportunities

  2018cites this paper
• Effect of polysaccharides from Vitis vinifera L. on NF-κB/IκB-α signal pathway and inflammatory factors in Alzheimer's model rats

  2018cites this paper
• Students for Students

  2018cites this paper
• DNA damage‐associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia

  2018cites this paper
• Neurobiological links between depression and AD: The role of TGF‐&bgr;1 signaling as a new pharmacological target

  2018cites this paper
• A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease

  2018cites this paper
• In what way can our knowledge of the role of Ach in sleep and memory consolidation be used to benefit Alzheimer’s research?

  2018cites this paper
• Cellular responses to amyloid-beta protofibrils : Focus on astrocytes, extracellular vesicles and antibody treatment

  2018cites this paper
• Polyphenols Derived from Lychee Seed Suppress Aβ (1-42)-Induced Neuroinflammation

  2018cites this paper
• Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities.

  2018cites this paper
• Inflammation as a central mechanism in Alzheimer's disease

  2018cites this paper
• Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer’s Disease and Brain Insulin Resistance, and Its Relation to Cancer

  2018cites this paper
• U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease

  2018cites this paper
• Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Neuroinflammation, Gut Microbiome, and Alzheimer’s Disease

  2018cites this paper
• The intestinal microbiome and Alzheimer's disease: A review

  2018cites this paper
• Therapeutic strategies for neurodegenerative disorders

  2017cites this paper
• Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease

  2017cites this paper
• An Evaluation of GABAB Receptors on Modulating Neuroinflammation in a Non-~Transgenic Animal Model of Alzheimer's Disease

  2017cites this paper
• Prostaglandin I2 is responsible for ameliorating prostaglandin E2 stress in stimulating the expression of tumor necrosis factor α in a β-amyloid protein -dependent mechanism.

  2017cites this paper
• Inhibitors of Poly(ADP-Ribose)Polymerase-1 as Agents Providing Correction of Brain Dysfunctions Induced by Experimental Diabetes

  2017cites this paper
• Protective effects of the Sophorae Fructus on cognitive impairment and neuroinflammatory alteration in an Aβ1-42-infused Alzheimer’s disease mouse model

  2017cites this paper
• The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells

  2017cites this paper
• Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?

  2017cites this paper
• Alzheimer ’ s disease : Efforts for discovering novel ways of therapy

  2017cites this paper
• Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure

  2017cites this paper
• Inhibitors of Poly(ADP-Ribose)Polymerase-1 as Agents Providing Correction of Brain Dysfunctions Induced by Experimental Diabetes

  2017cites this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cites this paper
• Effects of environmental enrichment on white matter glial responses in a mouse model of chronic cerebral hypoperfusion

  2017cites this paper
• PPARγ coactivator-1α (PGC-1α) protects neuroblastoma cells against amyloid-beta (Aβ) induced cell death and neuroinflammation via NF-κB pathway

  2017cites this paper
• Re‐imagining Alzheimer's disease – the diminishing importance of amyloid and a glimpse of what lies ahead

  2017cites this paper
• Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis.

  2017cites this paper